These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 3981815

  • 1. Phase II study of 7-N-(p-hydroxyphenyl)-mitomycin C (KW2083) in patients with advanced non-small cell carcinoma of the lung and metastatic pulmonary tumors.
    Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Sasaki Y, Fujita J, Futami H, Hoshi A.
    Jpn J Clin Oncol; 1985 Mar; 15(1):61-5. PubMed ID: 3981815
    [Abstract] [Full Text] [Related]

  • 2. [Phase II study of KW2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with carcinoma of the lung and metastatic pulmonary tumor].
    Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Shibuya M, Shimabukuro Z.
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):834-9. PubMed ID: 6882001
    [Abstract] [Full Text] [Related]

  • 3. [Phase I-II study of 7-N-(P-hydroxyphenyl)-mitomycin C (KW2083, M83)].
    Meguro S, Nagata T, Yokoyama K, Chinen T, Kobayashi T, Yamazaki H, Kuraishi Y, Ichiba, Abe M, Isogai Y.
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1818-22. PubMed ID: 6476844
    [Abstract] [Full Text] [Related]

  • 4. [Phase I study of KW2083 7-N-(p-hydroxyphenyl) mitomycin C].
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1844-50. PubMed ID: 7184379
    [Abstract] [Full Text] [Related]

  • 5. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
    Langer CJ, Millenson M, Rosvold E, Litwin S, McAleer CA, Bonjo CA, Ozols R.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
    [Abstract] [Full Text] [Related]

  • 6. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Aug; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 7. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.
    Langer CJ, Millenson M, O'Dwyer P, Kosierowski R, Alexander R, Litwin S, McAleer CA, Bonjo CA, Ozols R.
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):35-41. PubMed ID: 9007119
    [Abstract] [Full Text] [Related]

  • 8. [Phase II study of KW 2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with various cancers].
    Nishi I, Yokoyama T, Nakao I, Harashima S, Ohashi Y, Kanko T, Saito T.
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2513-9. PubMed ID: 6508315
    [Abstract] [Full Text] [Related]

  • 9. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F, Sica G, De Filippis S, Rosselli M, Saggio G, Guerriero G, Pompili P, Rea S.
    Anticancer Res; 2000 Dec; 20(3B):1985-90. PubMed ID: 10928138
    [Abstract] [Full Text] [Related]

  • 10. Phase II study of hexamethylmelamine alone and in combination with mitomycin C and vincristine in advanced breast carcinoma.
    Legha SS, Buzdar AU, Hortobagyi GN, DiStefano A, Wiseman CL, Yap HY, Blumenschein GR, Bodey GP.
    Cancer Treat Rep; 1979 Dec; 63(11-12):2053-6. PubMed ID: 118805
    [Abstract] [Full Text] [Related]

  • 11. Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.
    Lorusso V, Gebbia V, Spada M, Guida M, Cassano G, Brunetti C, Germano D, Nettis G, Izzi G, Galetta D, Giampaglia M, Silvestris N, Colucci G.
    Oncol Rep; 2005 Dec; 14(6):1547-51. PubMed ID: 16273254
    [Abstract] [Full Text] [Related]

  • 12. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A, Favaretto A, Oniga F, Festi G, Lauro S, Morabito A, Ossana L, Sartore F, DePoli F, Fiorentino MV.
    Cancer; 1996 Oct 15; 78(8):1701-7. PubMed ID: 8859183
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.
    Langer CJ, Leighton JC, Comis RL, O'Dwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Johnson S, Ozols RF.
    Semin Oncol; 1995 Aug 15; 22(4 Suppl 9):18-29. PubMed ID: 7544025
    [Abstract] [Full Text] [Related]

  • 14. A phase I/II trial of combination paclitaxel and carboplatin in advanced or metastatic non-small cell lung cancer: preliminary results of an ongoing study.
    Natale RB.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 15):34-7. PubMed ID: 8643968
    [Abstract] [Full Text] [Related]

  • 15. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.
    Langer CJ, Leighton J, McAleer C, Comis R, O'Dwyer P, Ozols R.
    Semin Oncol; 1995 Jun 15; 22(3 Suppl 6):64-9. PubMed ID: 7541156
    [Abstract] [Full Text] [Related]

  • 16. Ftorafur, adriamycin and mitomycin C (FAM II) for extensive bronchogenic adenocarcinoma and large cell carcinoma.
    Salvati F, Cruciani AR, De Marinis A, Nunziati F, Portalone L.
    Jpn J Clin Oncol; 1984 Mar 15; 14(1):3-6. PubMed ID: 6323790
    [Abstract] [Full Text] [Related]

  • 17. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
    Strauss GM, Lynch TJ, Elias AD, Jacobs C, Kwiatkowski DJ, Shulman LN, Carey RW, Grossbard ML, Jauss S, Sugarbaker DJ.
    Semin Oncol; 1995 Aug 15; 22(4 Suppl 9):70-4. PubMed ID: 7544029
    [Abstract] [Full Text] [Related]

  • 18. [Phase II study of bronchial artery infusion of mitomycin C in non-small cell lung cancer].
    Nakamura Y, Shimizu E, Hohjo F, Hashimoto Y, Mutsuura S, Yamasaki K, Mukai J, Tada T, Sone S, Yamashita T.
    Gan To Kagaku Ryoho; 1986 Dec 15; 13(12):3436-9. PubMed ID: 3024579
    [Abstract] [Full Text] [Related]

  • 19. [A clinical trial of a new mitomycin C derivative, KW-2083 (7-N-(p-hydroxyphenyl)-mitomycin C)].
    Takahashi K, Yokoyama M, Takahashi H, Wakui A.
    Gan To Kagaku Ryoho; 1985 Sep 15; 12(9):1787-93. PubMed ID: 4037809
    [Abstract] [Full Text] [Related]

  • 20. Phase II study of doxorubicin and mitomycin in non-small cell bronchogenic carcinoma.
    Coates AS, Fox RM, Woods RL, Levi JA, Tattersall MH.
    Cancer Treat Rep; 1982 Jan 15; 66(1):177-8. PubMed ID: 7053255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.